Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|December 8, 2016
Legislation That May Impact Specialty Pharmacy
Author(s)Laurie Toich, Assistant Editor
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.
Advertisement
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy
2
New Data Reshape Nonstatin Lipid Therapy Choices
3
After 180 Years, Multiple Myeloma Gets a Definition of Cure
4
FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D
5